Anti-angiogenic activity of rPAI-123 and vasa vasorum regression

被引:3
作者
Mulligan-Kehoe, Mary Jo [1 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Surg, Vasc Sect, Lebanon, NH 03756 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; ATHEROSCLEROTIC PLAQUE PROGRESSION; E-DEFICIENT MICE; CORONARY-ARTERIES; EXPERIMENTAL HYPERCHOLESTEROLEMIA; MATRIX METALLOPROTEINASES; VASCULAR-PERMEABILITY; EXTRACELLULAR-MATRIX; INTIMAL HYPERPLASIA; COLLAGEN MATRICES;
D O I
10.1016/j.tcm.2012.09.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vasa vasorum are unique networks of vessels that become angiogenic in response to changes in the vessel wall. Structural studies, using various imaging modalities, show that the vasa vasorum form a plexus of microvessels during the atherosclerotic disease process. The events that stimulate vasa vasorum neovascularization remain unclear. Anti-angiogenic molecules have been shown to inhibit/regress the neovascularization; they provide significant insight into vasa vasorum function, structure, and specific requirements for growth and stability. This review discusses evidence for and against potential stimulators of vasa vasorum neovascularization. Anti-angiogenic rPAI-1(23), a truncated isoform of plasminogen activator inhibitor-1 (PAI-1) stimulates a novel pathway for regulating plasmin activity. This mechanism contributes significantly to vasa vasorum regression/collapse and is discussed as a model of regression. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 50 条
[41]   Comparative in vitro/theoretical studies on the anti-angiogenic activity of date pollen hydro-alcoholic extract: Highlighting the important roles of its hot polyphenols [J].
Rasouli, Hassan ;
Norooznezhad, Amir Hossein ;
Rashidi, Tahereh ;
Hoseinkhani, Zohereh ;
Mahnam, Azadeh ;
Tarlan, Mitra ;
Moasefi, Narges ;
Mostafaei, Ali ;
Mansouri, Kamran .
BIOIMPACTS, 2018, 8 (04) :281-294
[42]   Suppression of VEGF expression through interruption of the HIF-1a and Akt signaling cascade modulates the anti-angiogenic activity of DAPK in ovarian carcinoma cells [J].
Park, Sung Taek ;
Kim, Boh-Ram ;
Park, Sung Ho ;
Lee, Jeong Heon ;
Lee, Eun-Ju ;
Lee, Seung-Hoon ;
Rho, Seung Bae .
ONCOLOGY REPORTS, 2014, 31 (02) :1021-1029
[43]   Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report Study [J].
Yan, Zheng ;
Ma, Jialin ;
Yao, Shuna ;
Yao, Zhihua ;
Wang, Haiying ;
Chu, Junfeng ;
Zhao, Shuang ;
Liu, Yanyan .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[44]   RETRACTED: The Anti-angiogenic Activity of NSITC, a Specific Cathepsin L Inhibitor (Retracted article. See vol. 43, pg. 4780, 2023) [J].
Rebbaa, Abdelhadi ;
Chu, Fei ;
Sudha, Thangirala ;
Gallati, Christine ;
Dier, Usawadee ;
Dyskin, Evgeny ;
Yalcin, Murat ;
Bianchini, Christine ;
Shaker, Olfat ;
Mousa, Shaker A. .
ANTICANCER RESEARCH, 2009, 29 (11) :4473-4481
[45]   6-Hydroxysugiol Isolated from Salvia yunnanensis Inhibits Proliferation and Migration of HepG2 Cells as well as Exhibits Potent Anti-Angiogenic Activity [J].
Zhuang, Wen-Ting ;
Xiang, Cheng ;
Zhu, Lu-Ping ;
He, Jing ;
Li, Bao-Cai ;
Li, Peng .
LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (10) :1457-1463
[46]   An andrographolide derivative AGP-26b exibitiing anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway [J].
Huang, Bin ;
Peng, Yuran ;
Li, Jingjing ;
Li, Shang ;
Sun, Yicheng ;
Wang, Decai ;
Yang, Binrui ;
Chan, Judy Yuet-Wa ;
Yu, Huidong ;
Leung, George Pak-Heng ;
Hoi, Maggie Pui-Man ;
Zhou, Guo-Chun ;
Lee, Simon Ming-Yuen .
MOLECULAR BIOSYSTEMS, 2017, 13 (03) :525-536
[47]   Suppression of STAT3 and HIF-1 Alpha Mediates Anti-Angiogenic Activity of Betulinic Acid in Hypoxic PC-3 Prostate Cancer Cells [J].
Shin, Jimin ;
Lee, Hyo-Jeong ;
Jung, Deok-Beom ;
Jung, Ji Hoon ;
Lee, Hyo-Jung ;
Lee, Eun-Ok ;
Lee, Seok Geun ;
Shim, Beom Sang ;
Choi, Seung Hoon ;
Ko, Seong Gyu ;
Ahn, Kwang Seok ;
Jeong, Soo-Jin ;
Kim, Sung-Hoon .
PLOS ONE, 2011, 6 (06)
[48]   Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial [J].
Schmitz-Winnenthal, Friedrich H. ;
Hohmann, Nicolas ;
Niethammer, Andreas G. ;
Friedrich, Tobias ;
Lubenau, Heinz ;
Springer, Marco ;
Breiner, Klaus M. ;
Mikus, Gerd ;
Weitz, Juergen ;
Ulrich, Alexis ;
Buechler, Markus W. ;
Pianka, Frank ;
Klaiber, Ulla ;
Diener, Markus ;
Leowardi, Christine ;
Schimmack, Simon ;
Sisic, Leila ;
Keller, Anne-Valerie ;
Koc, Ruhan ;
Springfeld, Christoph ;
Knebel, Philipp ;
Schmidt, Thomas ;
Ge, Yingzi ;
Bucur, Mariana ;
Stamova, Slava ;
Podola, Lilli ;
Haefeli, Walter E. ;
Grenacher, Lars ;
Beckhove, Philipp .
ONCOIMMUNOLOGY, 2015, 4 (04)
[49]   Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients [J].
Correale, Pierpaolo ;
Remondo, Cinzia ;
Carbone, Salvatore Francesco ;
Ricci, Veronica ;
Migali, Cristina ;
Martellucci, Ignazio ;
Licchetta, Antonella ;
Addeo, Raffaele ;
Volterrani, Luca ;
Gotti, Giuseppe ;
Rotundo, Maria Saveria ;
Tassone, Pierfrancesco ;
Sperlongano, Pasquale ;
Abbruzzese, Alberto ;
Caraglia, Michele ;
Tagliaferri, Pierosandro ;
Francini, Guido .
CANCER BIOLOGY & THERAPY, 2010, 9 (09) :685-693
[50]   A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities [J].
Bera, Hriday ;
Tan, Bee Jen ;
Sun, Lingyi ;
Dolzhenko, Anton V. ;
Chui, Wai-Keung ;
Chiu, Gigi Nagar Chee .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 67 :325-334